Retatrutide FAQ: Common Questions About the Triple-Receptor Agonist | Doctor Retatrutide

Retatrutide is the investigational triple-receptor agonist in Lilly's Phase 3 TRIUMPH program. These frequently asked questions address the most common topics across mechanism, clinical trial data, safety, and regulatory status.